Proteomics of Primary Hyperoxaluria Type 1 (PH1)

Clinical Trial ID NCT03067142

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03067142

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins. Anal Chem 2010 3.07
2 Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken) 2007 2.27
3 Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res 2013 1.20
4 Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One 2013 1.12
5 Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury. Kidney Int 2010 1.10
6 Estimating relative abundances of proteins from shotgun proteomics data. BMC Bioinformatics 2012 0.98
7 Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study. J Mass Spectrom 2009 0.95
8 Quantification of osteopontin in the urine of healthy and stone-forming men. Urol Res 1999 0.86
9 Preparation of urine samples for proteomic analysis. Methods Mol Biol 2008 0.80
Next 100